Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)

SHE:002581 Revenue

Shandong Sinobioway Biomedicine had revenue of 141.28M CNY in the quarter ending September 30, 2025, with 35.94% growth. This brings the company's revenue in the last twelve months to 257.74M, down -36.54% year-over-year. In the year 2024, Shandong Sinobioway Biomedicine had annual revenue of 360.41M, down -16.14%.

• Revenue (ttm): 257.74M
• Revenue Growth: -36.54%
• P/S Ratio: 19.38
• Revenue / Employee: 541.48K
• Employees: 476
• Market Cap: 4.99B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	360.41M	-69.39M	-16.14%
Dec 31, 2023	429.79M	72.71M	20.36%
Jan 1, 2023	357.08M	-45.63M	-11.33%
Jan 1, 2022	402.71M	125.88M	45.47%
Dec 31, 2020	276.83M	-290.81M	-51.23%